The Trial Better Podcast is ERT’s best practices series for clinical trial research. In this series, we discuss the factors that determine a successful clinical trial. Topics we cover are patient engagement, data architecture, FDA guidelines, wearable devices and much more. With our expert guests, we explore how to address the many unseen obstacles of clinical research.
All content for Trial Better: A Clinical Trials Podcast is the property of ERT and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Trial Better Podcast is ERT’s best practices series for clinical trial research. In this series, we discuss the factors that determine a successful clinical trial. Topics we cover are patient engagement, data architecture, FDA guidelines, wearable devices and much more. With our expert guests, we explore how to address the many unseen obstacles of clinical research.
ERT’s Vice President of Trial Oversight, Chief Diversity Officer, and Trial Better podcast host, Otis Johnson, is joined by Jennifer Stacey, Senior Vice President of Clinical Science and Operations at TriNetX for a conversation on real world evidence. They discuss how the non-global nature of real world evidence is changing for the better, and what that means for clinical research going forward.
Otis Johnson, host of Trial Better, is joined by Dr. Eric Siemers, President of Siemers Integration, LLC and a Distinguished Medical Advisor at Cogstate. They explore the setbacks and progress in recent Alzheimer’s disease research, and why the industry has reason to be optimistic about breakthroughs in this field in the near future.
Host Otis Johnson sits down with Ken Getz, Founder and Chairman of CISCRP and a professor at the Tufts University School of Medicine. They discuss how the perception of clinical research has evolved during the COVID-19 pandemic, as well as what the industry can do to take advantage of this unique opportunity to improve its relationship with the public.
Trial Better host and ERT’s Vice President of Trial Oversight, Otis Johnson, is joined by Dan Brenner, founder and CEO of 1nHealth. They discuss the changing landscape of patient recruitment, and what sponsors should consider as they aim to develop digital recruitment strategies that reflect the patient voice and virtual platform.
Host Jason Eger is joined by Jim Kremidas, Executive Director of the Association of Clinical Research Professionals. They discuss trends in the clinical research workforce and why sponsors should be concerned about the future development pipeline, as well as changes the industry can make to better prepare individuals for successful clinical research careers.
Dr. Fabian Sandoval of the Emerson Clinical Research Institute shares his firsthand experiences and learnings on the topic of patient diversity in clinical research, including the importance of sharing both his successes and failures and important considerations for sites that want to improve the diversity of their patient populations.
Dr. Fabian Sandoval of the Emerson Clinical Research Institute shares his firsthand experiences and learnings on the topic of patient diversity in clinical research, including the importance of sharing both his successes and failures and important considerations for sites that want to improve the diversity of their patient populations.
Host Jason Eger is joined by Dr. Diana Foster, Vice President of Strategy and Special Projects at the Society for Clinical Research Sites, to discuss how clinical research sites can help the industry improve patient diversity in clinical research.
Trial Better host and ERT’s Director of Operational Readiness, Jason Eger, is joined by Mike Wenger, Vice President of Patient Engagement at TrialScope. As they discuss the roadblocks a patient faces when searching for the right clinical trial opportunity, they also explore changes the industry can make to improve the matching process.
ERT’s Todd Rudo is joined on this episode of Trial Better by guest Dr. Ignacio Rodriguez, Head of Patient Safety for Immunology, Hepatology, and Dermatology at Novartis. Together they shed light on clinical research in the time of COVID-19, patient safety, and how studies are changing to ensure data quality.
In this edition of Trial Better, Deborah Collyar, an oncology patient advocate, discusses the importance of patient advocacy in clinical trials and her own personal advocacy in oncology. Learn more about the role of a patient advocate and the long-term benefits of keeping the patients and their needs at the center of clinical trials.
ERT’s Brian Smith and AliveCor’s Dr. David Albert explore how technological advancements can not only offer solutions to problems caused by COVID-19, but change the landscape of clinical research even after the pandemic is over.
ERT’s Jason Eger, Nadeeka Dias, and Chris Watson explore technology-based solutions for the challenges of vaccine trials and address the biggest issue facing the clinical research community today: COVID-19.
Nick Conn of Heart Health Intelligence and Jean-Philippe Couderc of VPG Medical join Trial Better for an expanded discussion of new passive health monitoring technologies, including how new devices can pass regulatory scrutiny and the impact they’ll have on patients in clinical trials
ATS and ERS have updated their guidance for pulmonary function testing in both healthcare and clinical research in October 2019 for the first time since 2005. Kevin McCarthy from ERT, a member of the ATS/ERS 2019 Spirometry Update Task Force, joins Trial Better to define the purpose and implications of the guidance as well as its applications in clinical trials.
ERT’s Jason Eger and VPG Medical’s Jean-Philippe Couderc dive into the limitless potential and promise of passive health monitoring technologies in clinical trials.
The Trial Better Podcast is ERT’s best practices series for clinical trial research. In this series, we discuss the factors that determine a successful clinical trial. Topics we cover are patient engagement, data architecture, FDA guidelines, wearable devices and much more. With our expert guests, we explore how to address the many unseen obstacles of clinical research.
